For example, EZH2 promotes tumor angiogenesis by silencing vasohibin1 in vascular endothelial cells [35], which suggests that we need to evaluate the advantages and disadvantages of EZH2 application in a holistic manner, and investigate whether other drugs need to be used in combination to avoid shortcomings when applied clinically. Here, EZH2 is linked to neoplasm.